Stock KROS KEROS THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Transcripts Keros Therapeutics, Inc.

Equities

KROS

US4923271013

Delayed Nasdaq
Other stock markets
 04:00:00 2024-06-03 pm EDT 		5-day change 1st Jan Change
48.67 USD +3.84% Intraday chart for Keros Therapeutics, Inc. +0.39% +22.41%
May. 28 Keros Therapeutics, Inc. Appoints Jean-Jacques Bienaimé to Its Board of Directors and to Serve as A Member of the Nominating Committee, Effective June 1, 2024 CI
May. 08 Earnings Flash (KROS) KEROS THERAPEUTICS Reports Q1 Revenue $83,000 MT

Transcripts

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Transcript : Keros Therapeutics, Inc. Presents at Morgan Stanley 19th Annual Global Healthcare Conference, Sep-10-2021 11:00 AM
Transcript : Keros Therapeutics, Inc. Presents at Jefferies 2021 Virtual Healthcare Conference, Jun-01-2021 02:00 PM
Transcript : Keros Therapeutics, Inc. Presents at H.C. Wainwright Virtual Global Life Sciences Conference, Mar-09-2021 07:00 AM
Transcript : Keros Therapeutics, Inc. Presents at SVB Leerink 10th Annual Global Healthcare Conference 2021, Feb-24-2021 01:40 PM
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. KROS Stock
  4. News Keros Therapeutics, Inc.
  5. Transcripts